dr. ferris discusses the rtog 3504 study in head and neck cancer
Published 7 years ago • 148 plays • Length 1:29Download video MP4
Download video MP3
Similar videos
-
0:54
dr. ferris on the safety profile for rtog 3504 for head and neck cancer
-
8:25
dr. ferris discusses the latest data in head and neck cancer
-
1:34
dr. ferris discusses nivolumab in head and neck cancer
-
1:36
dr. ferris on potential of nivolumab in head and neck cancer
-
2:25
dr. ferris on checkmate-141 trial in head and neck cancer
-
1:00
dr. ferris on pembrolizumab and nivolumab in head and neck cancer
-
1:17
dr. ferris on fda approval of nivolumab in patients with head and neck cancer
-
1:15
dr. ferris on significance of checkmate-141 trial for head and neck cancer
-
1:09
dr. ferris on immunotherapy in locally advanced head and neck cancer
-
2:01
dr. ferris on the updated data from checkmate-141 in head and neck cancer
-
0:54
dr. robert ferris on a phase iii study regarding nivolumab in head and neck cancer
-
8:44
biology of head and neck squamous cell carcinoma
-
1:11:32
understanding the impact of immunotherapy on head and neck cancer
-
1:06
dr. cohen discusses the keynote-040 trial in head and neck cancer
-
4:24
historic perspective on recurrent hnscc
-
6:51
pembrolizumab and nivolumab in recurrent hnscc
-
8:44
biology of head and neck squamous cell carcinoma
-
12:46
head and neck cancer: treatment of advanced disease
-
59:05
oncochallenge in locally advanced head and neck cancer: exploring new directions